deltorphin ii, ala(2)- has been researched along with moxonidine in 1 studies
| Studies (deltorphin ii, ala(2)-) | Trials (deltorphin ii, ala(2)-) | Recent Studies (post-2010) (deltorphin ii, ala(2)-) | Studies (moxonidine) | Trials (moxonidine) | Recent Studies (post-2010) (moxonidine) |
|---|---|---|---|---|---|
| 233 | 0 | 20 | 505 | 86 | 89 |
| Protein | Taxonomy | deltorphin ii, ala(2)- (IC50) | moxonidine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.7021 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.7021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fairbanks, CA; Kitto, KF; Posthumus, IJ; Stone, LS; Wilcox, GL | 1 |
1 other study(ies) available for deltorphin ii, ala(2)- and moxonidine
| Article | Year |
|---|---|
Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Aggression; Animals; Antihypertensive Agents; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Imidazoles; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Oligopeptides; Pain; Spinal Cord; Substance P | 2000 |